MCL MMJ Management/Team HIGHLIGHTS - Asst. Prof. David
MCL MMJ Management/Team HIGHLIGHTS - Asst. Prof. David (Dedi) Meiri PhD, the TECHNION, Israel. (Timeline highlights below - click on "See More"
Dr Meiri was a guest speaker at the 2017 UIC Symposium in Melbourne. Fx Medicine's Andrew Whitfield-Cooke discusses the journey of Cannabis and the work that David and his team from the TECHNION are doing in Israel. QBL:MCL is proud to have a research partnership with the TECHNION, Israel, supporting Dr. Meiri and his team with Medical Cannabis Research.
During the interview, Dr. Meiri stated that "There is no doubt that Cannabis is making a huge change...it's a very important medicine."
TIMELINE/INTERVIEW HIGHLIGHTS
00:24 Discusses the Technion's research with Cannabis and anti-cancer research, and Cannabinoid compounds..
03:58 Discusses seasonal effects on the changing of the active compounds within the cannabis plant and how that affects the potency of Cannabis extracts.
06:23 Discusses trials with children suffering severe Epilepsy, Autism, Chron's Disease.
08:40 Discusses growing conditions and climatic effects on the potency of the plant.
09:30 Discusses the fingerprints of cannabis extracts to identify different strains to match medical conditions.
11:00 Discusses GP's use of Medical cannabis when all other medications fail.
13:18 Discusses the use of Cannabis by GP's in Israel as part of their treatment arsenal to tackle disease.
14:30 Discusses introducing Cannabis earlier in the treatment paradigm for patients with severe illness.
16:00 Discusses the whirlpool of bureaucracy between government's, politicians, regulators and GP's to get Medical Cannabis into the hands of the professionals. Dr. Meiri discusses the Database project and current clinical trials.
19:08 Discusses psychiatrists use of neuro medicines and how medical cannabis can be trialled and proved for efficacy.
20:00 Discusses the Israeli's government full support for medical Cannabis research, education and training of professionals.
22:10 Discusses how the population of Israel has changed its view on the use of medicinal cannabis. Dr. Meiri's lab is the main reference centre for all Cannabis research for the Israeli Ministry of Health.
24:00 Discusses the ignorance around medicinal cannabis education in Australia and the concerns around the lack of education and good advice.
24:50 Dr. Meiri discusses how he has 100% support for his projects by the government of Israel, the Israeli medical system, the medical fraternity and pharma companies.
https://www.youtube.com/watch?v=_C3r4Ikrh1M
Deidi Me Iri FX Medicine Interview
2017 UIC Symposium.
youtube.com
See board and website for latest updates..
https://www.queenslandbauxite.com/
Here you have the possibility to take advantage on facts and info from QBL.Like the QBL on ASX website chapter, who can provide verified facts; here is regulated on-line stockbrokers suggestion, no games info and a good sum up.Contact information to the QBL Investor service, who can reply on questions, serviceminded.
Robert
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...
Continue Reading
Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...
Continue Reading
NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...
Continue Reading
Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...
Continue Reading
Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...
Continue Reading
Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...
Continue Reading
Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...
Continue Reading
Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...
Continue Reading
Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...
Continue Reading
China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of Nutex Health Inc. Nutex Health Inc. (NASDAQ: NUTX) is a key player in the healthcare sector, known for its innovative services and strategies aimed at enhancing patient care. As investors, it is crucial to stay informed about potential impacts to the company’s stock due to various legal challenges. Recent Legal Actions Recently, the law firm Kirby McInerney...
Continue Reading
A Wake-Up Call for Businesses If you thought the cyber threats were just a sideshow, think again. Sixty-five percent of businesses are tossing around the notion that a serious cyber attack could knock them out for good. Databarracks just unveiled its 2026 Data Health Check, airing out the gloomy stats we frankly can't ignore anymore. Cyber Attacks: More Than Just a...
Continue Reading
Overview of the Supplementary Prospectus Hargreave Hale AIM VCT plc has recently released a supplementary prospectus approved by the Financial Conduct Authority. This document is essential for investors seeking to understand recent developments regarding the company's financial situation. Purpose of the Supplementary Prospectus The supplementary prospectus is a regulatory...
Continue Reading
Carbliss Launches in Arizona: A Significant Expansion Carbliss has officially launched in Arizona, enhancing its reach and marking a pivotal point in the brand's journey. This premium ready-to-drink cocktail brand, known for its zero sugar, zero carb, and 100 calorie beverages, has made a notable impact in the beverage industry through a focus on quality and consumer...
Continue Reading
MicroStrategy's Bold Investment Strategies As the world watches Bitcoin prices soar to new heights, MicroStrategy's aggressive accumulation of Bitcoin has become a hot topic in the crypto community. Many traders and analysts are scrutinizing the company's strategy as it continues to amass significant Bitcoin holdings. Understanding Recent Developments Industry expert Alex...
Continue Reading